LeukoTrap SOLX B Additive (Haemonetics Manufacturing Inc)
Welcome to the PulseAid listing for the LeukoTrap SOLX B Additive drug offered from Haemonetics Manufacturing Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Haemonetics Manufacturing Inc |
| NON-PROPRIETARY NAME: | AS-7 B Additive Solution |
| SUBSTANCE NAME: | DEXTROSE, UNSPECIFIED FORM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-11-12 |
| END MARKETING DATE: | 0000-00-00 |
LeukoTrap SOLX B Additive HUMAN PRESCRIPTION DRUG Details:
| Item Description | LeukoTrap SOLX B Additive from Haemonetics Manufacturing Inc |
| LABELER NAME: | Haemonetics Manufacturing Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.78(g/30mL) |
| START MARKETING DATE: | 2015-11-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53157-000_eab5a1f9-bed2-4a42-9544-d5912cd267b8 |
| PRODUCT NDC: | 53157-000 |
| APPLICATION NUMBER: | NDA110059 |
Other DEXTROSE, UNSPECIFIED FORM Pharmaceutical Manufacturers / Labelers:
